(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

14 sep 2017 7:00 a.m. - 15 sep 2017 3:00 p.m.

1750 Rockville Pike, , Rockville, MD 20852 , USA

Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Volver a Agenda

Session 3: FDAAA Final Rule: Latest Updates from ClinicalTrials.gov

Session Chair(s)

Robert Paarlberg, MS

Robert Paarlberg, MS

Principal

Paarlberg & Associates LLC, United States

The Final Rule expanding the registry and results data bank specified in Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA) was published in the Federal Register on September 21, 2016. The Final Rule had an effective date of January 18, 2017 and a compliance date of April 18, 2017. This session will provide the latest update from NLM on the Final Rule including how the new requirements for results reporting.

Learning Objective :
  • Describe the requirements to report results under the Final Rule
  • Recognize how the Final Rule is impacting current processes
  • Explain how NLM is interpreting the Final Rule requirements

    • Speaker(s)

    Rebecca Williams, PharmD, MPH

    Speaker

    Rebecca Williams, PharmD, MPH

    Essex, Part of Emmes Group, United States

    Senior Clinical Trials Subject Matter Expert

    ¿Tiene una cuenta?

    Be informed and stay engaged.

    Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.